Concepedia

Author

Yoshiharu Maeda

Tokyo Metropolitan Komagome Hospital

Also Known As

Maeda, Yota, Takeshi Hattori, Y Maeda, Y. MAEDA, Y. Maeda, Y.Y. Maeda, Yoshiharu MAEDA, Yoshiharu Maeda

114

Publications

1.8K

Citations

22

H-Index

58

Concepts

All Affiliations

Tokyo Metropolitan Komagome HospitalTokyo Metropolitan Institute of Medical ScienceNational Cancer Centre JapanNational Cancer Center Hospital EastNational Cancer Center
YM

About

Yoshiharu Maeda is an author at Tokyo Metropolitan Komagome Hospital specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

14

1K

2

Health Sciences

4

4

618

3

Engineering

2

2

48

4

Biochemistry

1

1

47

5

Biomedical Engineering

1

1

23

Yoshiharu Maeda

×

29

Publications

1.6K

Citations

21

H-Index

YearCitations

Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.

M. Emi, Yutaka Fujiwara, Takashi Nakajima,

PubMed

1992

270

Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.

Rei Kikuchi-Yanoshita, Motoko Konishi, Sadayoshi Ito,

PubMed

1992

183

Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis.

Michiko Miyaki, Makoto Seki, Mitsumasa Okamoto,

PubMed

1990

178

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko,

The Lancet Oncology

2018

132

Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential

Hiroshi Iino, Masashi Fukayama, Yoshiharu Maeda,

Cancer

1994

106

Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer

Kensei Yamaguchi, T Shimamura, Ichinosuke Hyodo,

British Journal of Cancer

2006

68

Pulmonary and Pleural Thymoma: Diagnostic Application of Lymphocyte Markers to the Thymoma of Unusual Site

Masashi Fukayama, Yoshiharu Maeda, Nobuaki Funata,

American Journal of Clinical Pathology

1988

58

Establishment of a human malignant meningioma cell line with amplifiedc-myc oncogene

Kiyoko Tanaka, Chieko Sato, Yoshiharu Maeda,

Cancer

1989

56

Genetic Changes and Histopathological Grades in Human Hepatocellular Carcinomas

Motoko Konishi, Rei Kikuchi-Yanoshita, Kiyoko Tanaka,

Japanese Journal of Cancer Research

1993

56

Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine

Yasushi OKAJIMA, Shunyo KANAYAMA, Yoshiharu Maeda,

Thrombosis Research

1981

47

Page 1